Status: current, Defined. Date: 31-Dec 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3159741000168114 | tildrakizumab 100 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3159751000168111 | tildrakizumab 100 mg/mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tildrakizumab 100 mg/mL injection, syringe | Is a | tildrakizumab | true | Inferred relationship | Some | ||
| tildrakizumab 100 mg/mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tildrakizumab 100 mg/mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| tildrakizumab 100 mg/mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 353580679 | |
| tildrakizumab 100 mg/mL injection, syringe | has Australian BoSS | tildrakizumab | true | Inferred relationship | Some | 353580678 | |
| tildrakizumab 100 mg/mL injection, syringe | has intended active ingredient | tildrakizumab | true | Inferred relationship | Some | 353580678 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tildrakizumab 100 mg/mL injection, 1 mL syringe | has MPUU | True | tildrakizumab 100 mg/mL injection, syringe | Inferred relationship | Some | 1 |
| Ilumya 100 mg/mL injection, syringe | Is a | True | tildrakizumab 100 mg/mL injection, syringe | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Medicinal product unit of use reference set